Trauma-focused Cognitive Behavioral Therapy or Eye Movement Desensitization and Reprocessing: What Works in Children with Posttraumatic Stress Symptoms? A Randomized Controlled Trial
Overview
Psychiatry
Affiliations
To prevent adverse long-term effects, children who suffer from posttraumatic stress symptoms (PTSS) need treatment. Trauma-focused cognitive behavioral therapy (TF-CBT) is an established treatment for children with PTSS. However, alternatives are important for non-responders or if TF-CBT trained therapists are unavailable. Eye movement desensitization and reprocessing (EMDR) is a promising treatment for which sound comparative evidence is lacking. The current randomized controlled trial investigates the effectiveness and efficiency of both treatments. Forty-eight children (8-18 years) were randomly assigned to eight sessions of TF-CBT or EMDR. The primary outcome was PTSS as measured with the Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA). Secondary outcomes included parental report of child PTSD diagnosis status and questionnaires on comorbid problems. The Children's Revised Impact of Event Scale was administered during the course of treatment. TF-CBT and EMDR showed large reductions from pre- to post-treatment on the CAPS-CA (-20.2; 95% CI -12.2 to -28.1 and -20.9; 95% CI -32.7 to -9.1). The difference in reduction was small and not statistically significant (mean difference of 0.69, 95% CI -13.4 to 14.8). Treatment duration was not significantly shorter for EMDR (p = 0.09). Mixed model analysis of monitored PTSS during treatment showed a significant effect for time (p < 0.001) but not for treatment (p = 0.44) or the interaction of time by treatment (p = 0.74). Parents of children treated with TF-CBT reported a significant reduction of comorbid depressive and hyperactive symptoms. TF-CBT and EMDR are effective and efficient in reducing PTSS in children.
Psychometric accuracy of the Dutch Child and Adolescent Trauma Screener.
Kooij L, Hein I, Sachser C, Bouwmeester S, Bosse M, Lindauer R Eur J Psychotraumatol. 2025; 16(1):2450985.
PMID: 39835599 PMC: 11753014. DOI: 10.1080/20008066.2025.2450985.
Pfeiffer E, Unterhitzenberger J, Enderby P, Juusola A, Kostova Z, Lindauer R BMC Health Serv Res. 2024; 24(1):1202.
PMID: 39379921 PMC: 11460130. DOI: 10.1186/s12913-024-11689-3.
Ensink J, Henneman P, Venema A, Zantvoord J, den Kelder R, Mannens M Transl Psychiatry. 2024; 14(1):309.
PMID: 39060246 PMC: 11282249. DOI: 10.1038/s41398-024-02892-1.
Molero-Zafra M, Fernandez-Garcia O, Mitjans-Lafont M, Perez-Marin M, Hernandez-Jimenez M Front Psychiatry. 2024; 15:1360388.
PMID: 38868491 PMC: 11167727. DOI: 10.3389/fpsyt.2024.1360388.
Danielson C, Moreland A, Hahn A, Banks D, Ruggiero K JMIR Form Res. 2024; 8:e52835.
PMID: 38236634 PMC: 10835591. DOI: 10.2196/52835.